Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.
Transgenic expression of non-structural genes of Theiler's virus suppresses initial viral replication and pathogenesis of demyelination.
Clinical Application of Autologous Adipose Stem Cells in Patients with Multiple Sclerosis: Preliminary Results.
The "butterfly diagram": A gait marker for neurological and cerebellar impairment in people with multiple sclerosis.
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
Age at onset and seizure frequency affect white matter diffusion coefficient in patients with mesial temporal lobe epilepsy.
Acute ganglion cell loss during rapid visual recovery in optic neuritis.
[Monoclonal antibodies, overview and outlook of a promising therapeutic option].
Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy.
Ultrastructural, ssrDNA sequencing of Myxobolus prochilodus and Myxobolus porofilus and details of the interaction with the host Prochilodus lineatus.
Neuromuscular Electrical Stimulation Can Improve Walking Endurance In Individuals With Multiple Sclerosis: 2573 Board #96 June 3, 9: 30 AM - 11: 00 AM.
Non-Gaussian Diffusion Imaging Shows Brain Myelin and Axonal Changes in Obstructive Sleep Apnea.
Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.
Nuclear factor erythroid 2-related factor 2 is a critical target for the treatment of glucocorticoid-resistant lupus nephritis.
Association between Helicobacter pylori infection and multiple sclerosis: A systematic review and meta-analysis.
Addition of a general surgeon without addition of appropriate support is inadequate to improve outcomes of trauma patients in a rural setting: a cohort study of 1962 consecutive patients.
Weighted-SAMGSR: combining significance analysis of microarray-gene set reduction algorithm with pathway topology-based weights to select relevant genes.
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.
Role of Sonic Hedgehog Signaling in Oligodendrocyte Differentiation.
Glioblastoma multiforme masquerading as a tumefactive demyelinating lesion: Lessons learned at autopsy.
Tuning PAK Activity to Rescue Abnormal Myelin Permeability in HNPP.
Nerve conduction velocity in CMT1A: what else can we tell?
The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6.
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients.
Pages
« first
‹ previous
…
784
785
786
787
788
789
790
791
792
…
next ›
last »